Phase III clinical study of EGFR 20 exon insertion mutation in PLB1004 non-small cell lung cancer

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: cad94be3719658afad532e0d28bd5c870d3b5274
First added on: Sep 06, 2025